Zituvimet Xr Tablet, Film Coated, Extended Release
Product Images NDC 70710-1806

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Zituvimet Xr (NDC 70710-1806). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (98507577 C0c5 453d A80c 9e106b7f667e 01)

FDA Label Image

Image (98507577 C0c5 453d A80c 9e106b7f667e 02)

FDA Label Image

Image (98507577 C0c5 453d A80c 9e106b7f667e 03)

FDA Label Image

Image (98507577 C0c5 453d A80c 9e106b7f667e 04)

FDA Label Image

Zituvimet Xr, 50mg/500mg-image 01 (98507577 C0c5 453d A80c 9e106b7f667e 05)

FDA Label Image

Zituvimet Xr, 50mg/1,000mg-image 01 (98507577 C0c5 453d A80c 9e106b7f667e 06)

This is a description for a medication called Zituvimet XR, which is an extended-release tablet containing sitagliptin and metformin HCI. The recommended dosage is two tablets daily with a meal, preferably in the evening. The package is child-resistant and should be stored between 20°C to 25°C. It is advised to keep the medication out of reach of children and to use it within 30 days of opening. The medication guide should be dispensed to each patient along with the original container. This medication is distributed by Zydus Lifesciences LLC and manufactured by Zydus Pharmaceuticals (USA) Inc.*

FDA Label Image

Zituvimet Xr, 100mg/1,000mg-image 01 (98507577 C0c5 453d A80c 9e106b7f667e 07)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.